Noevir Holdings Co., Ltd. logo

Noevir Holdings Co., Ltd.

4928.T

JPXConsumer DefensiveHousehold & Personal Products

Latest quote

¥4,940

+¥65.00 · +1.33%

Aug 24, 3:30 PM JST

4928.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Noevir Holdings Co., Ltd. is a diversified Japanese conglomerate involved in the creation, production, and distribution of cosmetics, pharmaceuticals, and health food items. Its operations span a wide international footprint, including key markets such as Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia. The company's Cosmetics division focuses on developing and manufacturing skincare lines, featuring popular brands like Noevir and Nameraka Honpo. It also offers NOV hypoallergenic products and provides contract manufacturing services for cosmetic and quasi-drug formulations. Within its Pharmaceutical & Health Food segment, Noevir produces items such as Nanten Nodo Ame cough drops and functional beverages like Min Min Da Ha. This division also supplies a range of over-the-counter medications, including cold remedies, eye drops, and digestive aids, alongside various nutritional supplements. The "Other" segment broadens the company's scope through the sale and leasing of apparel and aircraft. Furthermore, the company is involved in manufacturing and selling toiletries, procuring and distributing makeup products and containers, and conducting market research. Its extensive aviation services encompass air transport, charter flight operations, ground handling, hanger rentals, and aircraft flight training, in addition to undertaking other aviation-related tasks. Noevir distributes its diverse product portfolio through multiple channels, including pharmacies, specialized retail outlets, general merchandise stores, supermarkets, e-commerce platforms, convenience stores, and a network of approximately 2,000 Noevir beauty studios and proprietary retail locations. Established in Tokyo, Japan, in 1964, Noevir Holdings Co., Ltd. maintains its headquarters there.

Industry
Household & Personal Products
Sector
Consumer Defensive
Headquarters
JP
CEO
Takashi Okura
Listed since
Oct 25, 2007
Employees
1,354

Market position

Day range

Current ¥4,940

52-week range

Current ¥4,940

Open
¥4,910
Previous close
¥4,875
Volume
103.7K
1.12× average
Average volume
92.28K
Average daily volume
Market cap
168.73B JPY
Beta
0.15
Market reference 1
50-day average
¥4,580.9
+7.84% above average
200-day average
¥4,543.25
+8.73% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
126.32B JPY
P/E (TTM)
21.1×
P/B (TTM)
3.31×
P/S (TTM)
2.66×
EV / EBITDA
10.58×
Earnings yield
5.27%
Free cash flow yield
3.71%
Dividend yield
4.66%

Profitability & efficiency

Gross margin
67.06%
Operating margin
15.69%
Net margin
12.59%
Return on equity
14.93%
Return on assets
10.50%
Return on invested capital
11.44%

Financial health

Debt / equity
0.01×
Current ratio
4.96×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends75%52%29%7%Gross margin, FY2021: 64.42%Gross margin, FY2022: 68.84%Gross margin, FY2023: 68.05%Gross margin, FY2024: 67.62%Gross margin, FY2025: 66.87%Operating margin, FY2021: 16.69%Operating margin, FY2022: 16.54%Operating margin, FY2023: 17.62%Operating margin, FY2024: 17.90%Operating margin, FY2025: 17.11%Net margin, FY2021: 12.45%Net margin, FY2022: 12.41%Net margin, FY2023: 12.27%Net margin, FY2024: 12.49%Net margin, FY2025: 12.41%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 64.42%. Gross margin FY2022 68.84%. Gross margin FY2023 68.05%. Gross margin FY2024 67.62%. Gross margin FY2025 66.87%. Operating margin FY2021 16.69%. Operating margin FY2022 16.54%. Operating margin FY2023 17.62%. Operating margin FY2024 17.90%. Operating margin FY2025 17.11%. Net margin FY2021 12.45%. Net margin FY2022 12.41%. Net margin FY2023 12.27%. Net margin FY2024 12.49%. Net margin FY2025 12.41%.

Income trends

Revenue

64.72B JPY+1.41%

Operating income

11.08B JPY-3.05%

Net income

8.03B JPY+0.75%
Income trends across reported periods70.56B JPY47.22B JPY23.89B JPY548.9M JPYRevenue, FY2021: 51.27B JPYRevenue, FY2022: 61.14B JPYRevenue, FY2023: 62.55B JPYRevenue, FY2024: 63.82B JPYRevenue, FY2025: 64.72B JPYOperating income, FY2021: 8.56B JPYOperating income, FY2022: 10.12B JPYOperating income, FY2023: 11.02B JPYOperating income, FY2024: 11.42B JPYOperating income, FY2025: 11.08B JPYNet income, FY2021: 6.38B JPYNet income, FY2022: 7.59B JPYNet income, FY2023: 7.67B JPYNet income, FY2024: 7.97B JPYNet income, FY2025: 8.03B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 51.27B JPY. Revenue FY2022 61.14B JPY. Revenue FY2023 62.55B JPY. Revenue FY2024 63.82B JPY. Revenue FY2025 64.72B JPY. Operating income FY2021 8.56B JPY. Operating income FY2022 10.12B JPY. Operating income FY2023 11.02B JPY. Operating income FY2024 11.42B JPY. Operating income FY2025 11.08B JPY. Net income FY2021 6.38B JPY. Net income FY2022 7.59B JPY. Net income FY2023 7.67B JPY. Net income FY2024 7.97B JPY. Net income FY2025 8.03B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue64.72B JPY63.82B JPY62.55B JPY61.14B JPY51.27B JPY
Cost of goods sold21.45B JPY20.67B JPY19.99B JPY19.05B JPY18.24B JPY
Gross profit43.28B JPY43.16B JPY42.56B JPY42.09B JPY33.03B JPY
Research and development1.13B JPY1.07B JPY1.03B JPY1.06B JPY1.04B JPY
Selling, general, and administrative32.2B JPY31.73B JPY31.54B JPY31.98B JPY22.44B JPY
Operating expenses32.2B JPY31.73B JPY31.54B JPY31.98B JPY24.47B JPY
Interest income94M JPY50M JPY30M JPY10M JPY8M JPY
Depreciation and amortization865M JPY1.01B JPY1.22B JPY1.45B JPY1.49B JPY
Operating income11.08B JPY11.42B JPY11.02B JPY10.12B JPY8.56B JPY
Net income8.03B JPY7.97B JPY7.67B JPY7.59B JPY6.38B JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
40.13

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates121.2388.8956.5524.22Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 8, 2024: actual 101.89, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 6, 2025: actual 28.49, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 8, 2025: actual 48.83, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 5, 2025: actual 43.42, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 7, 2025: actual 114.36, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 5, 2026: actual 38.7, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 13, 2026: actual 40.89, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 3, 2026: actual 40.13, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates18.14B16.91B15.68B14.45BQ1 '25No estimateQ2 '25No estimateQ3 '25No estimateQ4 '25No estimateQ1 '26No estimateQ2 '26No estimateQ3 '26MetQ4 '26Estimate
Q1 2025, reported Feb 6, 2025: actual 16.8B JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 8, 2025: actual 15.24B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 5, 2025: actual 15.25B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 7, 2025: actual 17.44B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 5, 2026: actual 15.47B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 13, 2026: actual 15.15B JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 3, 2026: actual 15.46B JPY, estimate 15.46B JPY, surprise 0.00%, Met estimate. Q4 2026, reported Nov 5, 2026: actual —, estimate 15.46B JPY, surprise —, Comparison unavailable.

4928.T peers

ETFs holding 4928.T

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 4928.T

research.disclaimer